Similar articles

• Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community.

  Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Bellamy MF, et al. J Am Coll Cardiol. 2002 Nov 20;40(10):1723-30. doi: 10.1016/s0735-1097(02)02496-8. J Am Coll Cardiol. 2002. PMID: 12446053 Clinical Trial.
• Statins and aortic stenosis in the context of ratio of low- to high-density lipoprotein cholesterol.

  Yilmaz MB. Yilmaz MB. J Am Coll Cardiol. 2007 Jul 17;50(3):289-90; author reply 290. doi: 10.1016/j.jacc.2007.02.072. Epub 2007 Jun 29. J Am Coll Cardiol. 2007. PMID: 17631225 No abstract available.
• Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.

  Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Novaro GM, et al. Circulation. 2001 Oct 30;104(18):2205-9. doi: 10.1161/hc4301.098249. Circulation. 2001. PMID: 11684632
• SALTIRE-RAAVE: targeting calcific aortic valve disease LDL-density-radius theory.

  Rajamannan NM, Greve AM, Moura LM, Best P, Wachtell K. Rajamannan NM, et al. Expert Rev Cardiovasc Ther. 2015 Apr;13(4):355-67. doi: 10.1586/14779072.2015.1025058. Expert Rev Cardiovasc Ther. 2015. PMID: 25797901 Review.
• Statins for progression of aortic valve stenosis and the best evidence for making decisions in health care.

  Thiago L, Tsuj SR, Atallah AN, Puga ME, de Góis AF. Thiago L, et al. Sao Paulo Med J. 2011 Jan 6;129(1):41-5. doi: 10.1590/s1516-31802011000100008. Sao Paulo Med J. 2011. PMID: 21437508 Free PMC article. Review.